They found that the majority of colorectal cancers expressed SMAD4 and TGF-β1 and suggested that hypoxia-induced TGF-β1 production by tumor cells may suppress the tumor-infiltrating immune cells and contribute to their invasiveness through autocrine activation of Smad signaling (32). The gene discussed is SMAD4; the disease is colorectal cancer.